Comparative analysis of efficacy and tolerability of tramadol versus diclofenac in treatment of knee osteoarthritis

Rima Kanjiya, Ravi Kotadia
{"title":"Comparative analysis of efficacy and tolerability of tramadol versus diclofenac in treatment of knee osteoarthritis","authors":"Rima Kanjiya, Ravi Kotadia","doi":"10.18203/2319-2003.ijbcp20213749","DOIUrl":null,"url":null,"abstract":"Background: Present study was conducted on patients of osteoarthritis (OA) treated with the traditional drug diclofenac sodium and compares it with tramadol, with the primary objective for determining effectiveness and tolerability based on WOMAC scores.Methods: The study was conducted as a randomized clinical study of the effectiveness and tolerability of tramadol versus diclofenac in the treatment of knee OA, at Tertiary care institute of Gujarat in the department of orthopedics. Consecutive patients were allotted serially in two groups; tramadol group (n=75) One tablet orally twice daily for 8 weeks. Diclofenac group (n75) patients received 75 mg oral dose of diclofenac 2 times daily for a period of 8 weeks. Overall improvement was evaluated through various parameters.Results: About 33% decrease in the scoring of stiffness domain of the WOMAC OA index questionnaire in the tramadol group and a 21% decline in the diclofenac group was observed. There was a 65% decrease in the scoring of knee joint tenderness questionnaire in the tramadol group and a 44% reduction in the diclofenac group. Tramadol was found to be more effective in improving the WOMAC OA index. WOMAC score (overall) and knee joint tenderness scores were also improved by tramadol than diclofenac.Conclusions: There was a significant improvement in the standard of life in patients suffering from knee OA when treated with tramadol. Tolerability was better with tramadol than diclofenac.","PeriodicalId":13901,"journal":{"name":"International Journal of Basic & Clinical Pharmacology","volume":"8 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Basic & Clinical Pharmacology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18203/2319-2003.ijbcp20213749","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Present study was conducted on patients of osteoarthritis (OA) treated with the traditional drug diclofenac sodium and compares it with tramadol, with the primary objective for determining effectiveness and tolerability based on WOMAC scores.Methods: The study was conducted as a randomized clinical study of the effectiveness and tolerability of tramadol versus diclofenac in the treatment of knee OA, at Tertiary care institute of Gujarat in the department of orthopedics. Consecutive patients were allotted serially in two groups; tramadol group (n=75) One tablet orally twice daily for 8 weeks. Diclofenac group (n75) patients received 75 mg oral dose of diclofenac 2 times daily for a period of 8 weeks. Overall improvement was evaluated through various parameters.Results: About 33% decrease in the scoring of stiffness domain of the WOMAC OA index questionnaire in the tramadol group and a 21% decline in the diclofenac group was observed. There was a 65% decrease in the scoring of knee joint tenderness questionnaire in the tramadol group and a 44% reduction in the diclofenac group. Tramadol was found to be more effective in improving the WOMAC OA index. WOMAC score (overall) and knee joint tenderness scores were also improved by tramadol than diclofenac.Conclusions: There was a significant improvement in the standard of life in patients suffering from knee OA when treated with tramadol. Tolerability was better with tramadol than diclofenac.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
曲马多与双氯芬酸治疗膝关节骨性关节炎的疗效及耐受性比较分析
背景:本研究采用传统药物双氯芬酸钠治疗骨关节炎(OA)患者,并将其与曲马多进行比较,主要目的是根据WOMAC评分来确定疗效和耐受性。方法:该研究是在古吉拉特邦三级保健研究所骨科进行的曲马多与双氯芬酸治疗膝关节OA的有效性和耐受性的随机临床研究。连续患者依次分为两组;曲马多组(75例)口服1片,每日2次,连用8周。双氯芬酸组(n75例)患者给予双氯芬酸75 mg口服剂量,每日2次,疗程8周。通过各种参数评估整体改善情况。结果:曲马多组WOMAC OA指数问卷僵硬域评分下降33%,双氯芬酸组下降21%。曲马多组膝关节压痛问卷评分降低65%,双氯芬酸组降低44%。曲马多对改善WOMAC OA指数更为有效。与双氯芬酸相比,曲马多也改善了WOMAC评分(总体)和膝关节压痛评分。结论:曲马多治疗可显著改善膝关节OA患者的生活水平。曲马多的耐受性优于双氯芬酸。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Current status of calcitonin gene-related peptide-based therapies in migraine: a scoping review Efficacy of current treatments against hepatitis C virus Adverse drug reactions to first line anti-tuberculosis drugs in newly diagnosed tuberculosis patients Comparing the effect of statins on hepatic fibrosis induced by carbon tetrachloride in Wistar rats Prescription audit of antihypertensive drugs used in stroke patients in a tertiary care teaching hospital
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1